Knockdown of FAP expression attenuates the activity of the PI3K/AKT/mTOR signaling pathway, thereby inhibiting the growth of RCC, suggesting that targeting FAP may be a potential therapeutic strategy for RCC treatment.44 The gene discussed is AKT1; the disease is renal cell carcinoma.